Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

Shingles is a painful, blistering rash that can last for weeks—often disrupting work, family time, sleep, and daily routines.

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based ...

GSK plc’s strong oncology growth, highlighted by Ojjaara sales and an upgraded 2025 outlook, earns a continued 'Buy' rating.

ANTWERPEN, BE / ACCESS Newswire / October 9, 2025 /OMP, a leader in supply chain planning solutions, is spotlighting at the ...

Part of a pharmaceutical factory which opened more than 75 years ago will be demolished. GSK plc (formerly GlaxoSmithKline) ...

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. GSK plc (NYSE:GSK) is one of the top performers on ...

Dame Emma Walmsley will step down as GSK’s chief executive at the end of the year, concluding nine years at the helm of ...

U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after ...

Ms Walmsley was the first woman to run a major pharmaceutical company when she became chief executive in 2017. The FTSE ...

Health Secretary Robert F. Kennedy Jr. and the Food and Drug Administration on Monday enlisted GSK to help fast-track ...

Luke Miels is to succeed Emma Walmsley as the British drugmaker’s chief executive starting from Jan.1.